Bridgefront Capital’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-40,245
Closed -$813K 606
2024
Q2
$813K Buy
40,245
+25,891
+180% +$431K 0.34% 80
2024
Q1
$222K Sell
14,354
-25,268
-64% -$285K 0.17% 285
2023
Q4
$353K Buy
39,622
+25,284
+176% +$187K 0.27% 140
2023
Q3
$90.2K Sell
14,338
-21,019
-59% -$156K 0.06% 363
2023
Q2
$332K Buy
+35,357
New +$351K 0.18% 219

Other funds holding HIMS

Bridgefront Capital's HIMS Position: Q3 2024 in Review

Bridgefront Capital sold out of Hims & Hers Health (HIMS) in Q3 2024, closing a stake of 40,245 shares — an estimated $813K sold.

Bridgefront Capital first reported a position in HIMS in Q2 2023 and held it in 5 quarters. The position peaked at $813K in Q2 2024. 308 funds tracked by Wall St. Rank hold HIMS as of Q3 2024.

  • Bridgefront Capital reported no remaining Hims & Hers Health position as of Q3 2024 after selling out during the quarter.
  • Bridgefront Capital sold 40,245 Hims & Hers Health shares in Q3 2024, an estimated $813K.
  • Bridgefront Capital first reported a position in Hims & Hers Health in Q2 2023 and held it in 5 quarters.
  • Bridgefront Capital's Hims & Hers Health position peaked at $813K in Q2 2024.
  • 308 funds tracked by Wall St. Rank held Hims & Hers Health as of Q3 2024.

Based on Bridgefront Capital's 13F filing for Q3 2024, filed 14 Nov 2024.